Dopamine receptor
Encyclopedia : D : DO : DOP : Dopamine receptor
The dopamine receptors are a class of metabotropic G protein-coupled receptors with the neurotransmitter dopamine as their endogenous ligand.
Dopamine receptor types
| D1-like | D2-like | |||||
| D1 | D5 | D2 | D3 | D4 | ||
|---|---|---|---|---|---|---|
| Apomorphine
|
| |||||
| Fenoldopam
|
| ?
| ||||
| SKF 38393
|
| |||||
| SKF 82958
| ||||||
| Dihydrexidine
| ||||||
| Quinpirole |
| |||||
| Haloperidol | ||||||
| ? | ||||||
| ? | ||||||
| Flupentixol | ||||||
| ? | ||||||
| ? | ? | |||||
| Fluphenazine | ||||||
| ? | ? | ? | ? | |||
| SCH 23390 | ||||||
| Spiperone | ? | |||||
| ? | ? | |||||
| Raclopride | ||||||
| Clozapine | ||||||
| — | ||||||
There are five types of dopamine receptor.
The D1 and D5 receptors are members of the D1-like family of dopamine receptors whereas the D2, D3 and D4 receptors are members of the D2-like family.
- D1-like: Activation of the D1-like family receptors is coupled to increases in cAMP and is typically excitatory.
- * D1 ("DRD1", OMIM [126449])
- * D5 ("DRD5", OMIM [126453])
- D2-like: D2-like activation reduces cAMP and is typically inhibitory.
- * D2 ("DRD2", OMIM [126450]). There is a short version of D2 (D2Sh) and a long version of D2 (D2Lh). The D2Sh are pre-synaptic situated, having modulatory functions (called autoreceptor, they regulates the neurotransmission by feed-back mechanisms, i.e., synthesis, storage and release of dopamine into the synaptic cleft) and the D2Lh, which may have the classic function of a post-synaptic receptor, i.e., keep going on the neurotransmission (excitatory or inhibitory) once blocked by a receptor antagonist or stimulated by the endogenous neurotransmitter itself or a synthetic full or partial agonist.
- * D3 ("DRD3", OMIM [126451])
- * D4 ("DRD4", OMIM [126452]). D4 has the following variants D4.2, D4.3a, D4.3b, D4.4a, D4.4b, D4.4c, D4.4d, D4.4e, D4.5a, D4.5b, D4.6a, D4.6b, D4.7a, D4.7b, D4.7c, D4.7d, D4.8, D4.10.
In schizophrenics and patients with Tardive dysphrenia, D2 receptors are supposed to exist in higher than normal levels on the dopaminergic mesolimbic pathway, and antipsychotic drugs aim to block these may cause its upregulation.
References
- Zimmerberg, B., ["Dopamine receptors: A representative family of metabotropic receptors], Multimedia Neuroscience Education Project (2002)
- FROTA LH. ["Partial Agonists in the Schizophrenia Armamentarium. Tardive Dysphrenia: The newest challenge to the last generation atypical antipsychotics drugs?"] J Bras Psiquiatr 2003; Vol 52 Supl 1;14-24.
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.
